Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis
Journal Title: Journal of Enam Meical College - Year 2016, Vol 6, Issue 3
Abstract
Sulfasalazine is a well-established disease-modifying agent. It is commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. The most frequently reported adverse effects are gastrointestinal effects, headache, dizziness and rash; myelosuppression can also occur. Patients treated with sulfasalazine can develop thrombocytopenia which is immune mediated. We report a case of ulcerative colitis that was on sulfasalazine subsequently developing thrombocytopenia.
Authors and Affiliations
NS Neki, Ankur Jain
Keywords
Related Articles
- EP ID EP36279
- DOI https://doi.org/10.3329/jemc.v6i3.29685
- Views 292
- Downloads 0
A 50-Year-Old Male with Dapsone Hypersensitivity Syndrome
Dapsone, diamino-diphenyl sulfone, is an antibacterial and anti-inflammatory drug which is used worldwide for treating many diseases, such as leprosy, dermatitis herpetiformis, linear IgA bullous dermatosis, chronic bul...
Cat Scratch Disease
We report a case of cat scratch disease in a young boy who presented in the outpatient department of Enam Medical College Hospital, Savar, Dhaka with history of cat scratch and regional painful lymphadenopathy. The dia...
Fight against Suicide
Abstract not available
Frequency and Sensitivity of Extended Spectrum Beta-Lactamase Positive Organisms in a Secondary and Tertiary Level Hospital Network in Dhaka
Background: Extended spectrum β-lactamase (ESBL) positive organisms are now a global health concern including in Bangladesh. These are associated with treatment failure, increased morbidity and mortality and increased...
From the Desk of Editor-in-Chief 6(1)
Abstract not available